Alterola Biotech (Alterola Biotech) Additional Paid-In Capital : $9.66 Mil(As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Alterola Biotech Additional Paid-In Capital?

Alterola Biotech's quarterly additional paid-in capital declined from Jun. 2023 ($19.86 Mil) to Sep. 2023 ($7.58 Mil) but then increased from Sep. 2023 ($7.58 Mil) to Dec. 2023 ($9.66 Mil).

Alterola Biotech's annual additional paid-in capital increased from Sep. 2020 ($0.77 Mil) to Mar. 2022 ($18.08 Mil) and increased from Mar. 2022 ($18.08 Mil) to Mar. 2023 ($18.93 Mil).

Alterola Biotech Additional Paid-In Capital Historical Data

The historical data trend for Alterola Biotech's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterola Biotech Additional Paid-In Capital Chart

Alterola Biotech Annual Data

Trend

Sep13

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Mar22

Mar23

Additional Paid-In Capital

Get a 7-Day Free Trial

0.54

0.65

0.77

18.08

18.93

Alterola Biotech Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															18.93	18.93	19.86	7.58	9.66

Alterola Biotech Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Alterola Biotech Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Alterola Biotech's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterola Biotech (Alterola Biotech) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alterola Biotech Inc (OTCPK:ABTI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

47 Hamilton Square, Birkenhead, Merseyside, GBR, CH41 5AR

Website

https://www.alterolabio.com

Alterola Biotech Inc is a development stage company. The company develops chewing gums to deliver nutraceutical/functional ingredients for applications such as appetite suppressant, cholesterol suppressant, vitamin delivery, antioxidant delivery, and motion sickness suppressant.

Executives

Bright Green Corp

10 percent owner

401 EAST LAS OLAS BLVD., SUITE 1400, FT. LAUDERDALE FL 33301